Maryland SB 353: Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)

Status: Vetoed by the Governor (Duplicative) (as of 2022-05-27)

State: Maryland · Session: 2022 · Bill: SB 353

Sponsors: Augustine, Beidle, Benson, Elfreth, Hayes, Jackson, King, Klausmeier, Lam, Lee, Patterson, Pinsky, Sydnor, Washington

View Maryland SB 353 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.